Lu, D.; Nagelberg, A.; Chow, J.L.; Chen, Y.T.; Michalchuk, Q.; Somwar, R.; Lockwood, W.W.
MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis. Cancers 2022, 14, 1378.
https://doi.org/10.3390/cancers14061378
AMA Style
Lu D, Nagelberg A, Chow JL, Chen YT, Michalchuk Q, Somwar R, Lockwood WW.
MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis. Cancers. 2022; 14(6):1378.
https://doi.org/10.3390/cancers14061378
Chicago/Turabian Style
Lu, Daniel, Amy Nagelberg, Justine LM Chow, Yankuan T Chen, Quentin Michalchuk, Romel Somwar, and William W. Lockwood.
2022. "MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis" Cancers 14, no. 6: 1378.
https://doi.org/10.3390/cancers14061378
APA Style
Lu, D., Nagelberg, A., Chow, J. L., Chen, Y. T., Michalchuk, Q., Somwar, R., & Lockwood, W. W.
(2022). MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis. Cancers, 14(6), 1378.
https://doi.org/10.3390/cancers14061378